[1]Fretz,Heinz;Valdenaire,Anja;Pothier,Julien;Hilpert,Kurt;Gnerre,Carmela;Peter,Oliver;Leroy,Xavier;Riederer,MarkusA.[JournalofMedicinalChemistry,2013,vol.56,#12,p.4899-4911]
[1]Fretz,Heinz;Valdenaire,Anja;Pothier,Julien;Hilpert,Kurt;Gnerre,Carmela;Peter,Oliver;Leroy,Xavier;Riederer,MarkusA.[JournalofMedicinalChemistry,2013,vol.56,#12,p.4899-4911]
[1]Fretz,Heinz;Valdenaire,Anja;Pothier,Julien;Hilpert,Kurt;Gnerre,Carmela;Peter,Oliver;Leroy,Xavier;Riederer,MarkusA.[JournalofMedicinalChemistry,2013,vol.56,#12,p.4899-4911]
[1]JournalofMedicinalChemistry,2013,vol.56,p.4899-4911
Title: Heinz Fretz, et al. Identification of 2 (2-(1-Naphthoyl)-8-fluoro-3,4-dihydro 1H pyrido,3 bindol-5(2H) yl)acetic Acid (Setipiprant/ACT 129968), a Potent, Selective, and Orally Bioavailable Chemoattractant Receptor-Homologous Molecule Expressed on Th2 Cells (CRTH2) Antagonis. 2013.